The effects of Phor21-FSH and cetrorelix (CTX) treatments on tumor growth (xenograft) (% of control) in HEK293-FSHR and LNCaP cells were significantly decreased in HEK-293-FSHR cells within the xenografts treated with 8 mg and 2 mg of Phor21-FSHβ33–55 C/S alone or 8 mg with or without 5 mg of CTX (Fig S5). The gene discussed is FSHR; the disease is neoplasm.